Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial
Titel:
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial
Auteur:
Mateo, Joaquin Porta, Nuria Bianchini, Diletta McGovern, Ursula Elliott, Tony Jones, Robert Syndikus, Isabel Ralph, Christy Jain, Suneil Varughese, Mohini Parikh, Omi Crabb, Simon Robinson, Angus McLaren, Duncan Birtle, Alison Tanguay, Jacob Miranda, Susana Figueiredo, Ines Seed, George Bertan, Claudia Flohr, Penny Ebbs, Berni Rescigno, Pasquale Fowler, Gemma Ferreira, Ana Riisnaes, Ruth Pereira, Rita Curcean, Andra Chandler, Robert Clarke, Matthew Gurel, Bora Crespo, Mateus Nava Rodrigues, Daniel Sandhu, Shahneen Espinasse, Aude Chatfield, Peter Tunariu, Nina Yuan, Wei Hall, Emma Carreira, Suzanne de Bono, Johann S
Verschenen in:
Lancet oncology
Paginering:
Jaargang 21 () nr. 1 pagina's 162-174
Jaar:
2020
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license